MedPath

PIEB-PCEA vs CEI-PCEA for Abdominal Oncological Surgery. A Randomized Prospective Clinical Trial

Not Applicable
Completed
Conditions
Pain, Postoperative
Interventions
Procedure: Programmed intermittent epidural bolus application (PIEB)
Procedure: Continous epidural analgesia
Registration Number
NCT03378804
Lead Sponsor
Philipps University Marburg Medical Center
Brief Summary

The aim of the study is to compare programmed intermittent bolus application and continuous epidural infusion with regard to additionally applied patient-controlled volume of local anesthesia and quality of analgesia.

Detailed Description

Usually, patient controlled epidural analgesia (PCEA) is performed with a constant background infusion and patient-controlled bolus applications. An alternative approach is to give boluses at a regular rate for basic medication, instead of the continuous background infusion, maintaining the same amount of medication delivered per hour, (Programmed Intermittent Epidural Bolus injection; PIEB). In both cases, the patient has the option to trigger additional boluses. PIEB has been applied successfully in pain relief for lumbar epidural anesthesia in obstetrics, with better quality of analgesia and less total volume of local anesthetic required. It is assumed that the higher pressure in the epidural space with bolus injection results in a better and more uniform spread of the local anesthetic. In this study the PIEB-mode will be applied in major gynecological and abdominal surgery. In order to address the possibility that the different types of surgery result in different degrees of postoperative pain, the patients are stratified in three groups and randomized within these groups (Wertheim, Whipple, major colon surgery).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria
  • Abdominal tumors in gynecology and general surgery
  • Enlightenment and written consent to the investigation
Exclusion Criteria
  • refusal to participate
  • pregnancy and breast feeding period
  • general contraindications for thoracic epidural anesthesia (e.g. coagulation disorders, --anticoagulation according to the guidelines of DGAI)
  • Impossibility to place the epidural catheter correctly
  • Known allergy to the drugs used in the study
  • Lack of understanding how to use the patient-controlled system
  • postoperative follow-up respiratory assistance

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PIEB-PCEAProgrammed intermittent epidural bolus application (PIEB)Programmed intermittent epidural bolus (PIEB) application of ropivacaine 0.2% with patient-controlled epidural analgesia: The background rate is set at 6ml per hour. The patient-controlled bolus function is programmed with 4ml at a lock-out interval of 30min.
CEI-PCEAContinous epidural analgesiaContinous epidural analgesia with patient-controlled analgesia using ropivacaine 0.2%: The background rate is set at 6 ml / h continuously. The patient-controlled bolus function is programmed in with 4ml at a lock-out interval of 30min.
Primary Outcome Measures
NameTimeMethod
Number of additional patient-controlled bolus of ropivacaine 0.2% (consumption in ml)Beginning of operation -6 pm on the second postoperative day

The patient-controlled bolus function is programmed with 4ml at a lock-out interval of 30min. The number of additional patient-controlled boli will be read off the epidural pump at 6 pm on the day of surgery, 6 pm on the 1st day and 6 pm on the 2nd day

Secondary Outcome Measures
NameTimeMethod
quality of analgesiaAt 6 pm on the day of surgery, 6 pm on the 1st day and 6 pm on the 2nd day

Measured on a visual analog scale of 0-10 (0="no pain" ; 10= "worst imaginable pain"

Trial Locations

Locations (1)

Philipps Universität Marburg

🇩🇪

Marburg, Germany

© Copyright 2025. All Rights Reserved by MedPath